ODS Medical
ODS Medical is a Montréal-based medical device company developing an exclusive Raman spectroscopy system for medical applications. Founded in 2015, the firm has historically targeted medtech commercialization but shows operational distress signals including an expired corporate domain and no documented commercial activity.
- Company typePrivate
- Founded2015
- HeadquartersMontréal, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What ODS Medical does
ODS Medical is a Montréal-based medical device company founded in 2015 that is developing a Raman spectroscopy system intended for medical applications, with the company describing the platform as exclusive to them. Raman spectroscopy uses inelastic light scattering to characterize molecular composition of tissue, and in a surgical/oncology context it is typically applied toward intraoperative margin assessment or non-invasive diagnostic guidance. The company was founded by Kirk Urmey, Kevin Petrecca (who serves as CMO), and Eric Marple, with Christopher Kent serving as President and CEO.
The business has historically targeted the medtech commercialization pathway, drawing backing from a sequence of Canadian and international supporters — Anges Quebec (2016), Creative Destruction Lab (2017), MedTech Innovator (2018), and a 2020 round led by Zoic Capital with participation from MEDTEQ+ and SGInnovate. These investors and program affiliations suggest a strategy of leveraging Quebec-based angel capital, accelerator validation, and pan-North-American and Singapore ecosystem access to advance the technology toward regulatory clearance and commercial launch.
As of the data captured here, ODS Medical shows material operational distress signals: its corporate website (odsmed.com) has expired and displays only a registrar's Expired Registration Recovery Policy notice, the operating status is flagged as "closed," and there is no record of products in market, customer relationships, pricing, distribution, or revenue. The structured contact information resolves to Key-Systems GmbH, a German domain registrar, rather than to the company itself. No patents, regulatory approvals, certifications, or post-2020 strategic activity are documented, indicating the company is either dormant, in turnaround, or no longer an active operating entity.
ODS Medical firmographics
Firmographics- Name
- ODS Medical
- Legal name
- Key-Systems GmbH
- Website
- https://odsmed.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Closed
- Headcount range
- 11–50 employees
- Short description
- ODS Medical is a Montréal-based medical device company developing an exclusive Raman spectroscopy system for medical applications. Founded in 2015, the firm has historically targeted medtech commercialization but shows operational distress signals including an expired corporate domain and no documented commercial activity.
- Ownership category
- akta.pro rank
ODS Medical industry classification
Industry- Product category
- Medical Diagnostic Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF), DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)
Keywords
Where ODS Medical is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Markets served
ODS Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations
ODS Medical product offering
Product offeringCore offering
ODS Medical is a medical device company developing and seeking to commercialize an exclusive Raman spectroscopy system. The system is positioned for diagnostic and intraoperative clinical applications, enabling optical tissue analysis for medical and surgical use cases. The company's primary commercial objective is to bring this proprietary Raman spectroscopy platform to healthcare markets.
Product overview
No product information available. The website (odsmed.com) displays only an expired domain registration notice with no product, service, or technology offerings.
Differentiator
Problem solved
Functional benefit
Products and services
- Raman Spectroscopy System An exclusive Raman spectroscopy-based medical device intended for clinical and intraoperative diagnostic applications, enabling optical tissue analysis for healthcare providers and surgical teams.
Companies that use ODS Medical
Customer profileIdeal customer profiles1 record
ODS Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ODS Medical partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
ODS Medical competitors and assessment
Company assessmentDirect peers
- Mauna Kea Technologies: Commercializes the Cellvizio probe-based optical biopsy platform for in-vivo tissue characterization during endoscopy and surgery. Directly comparable to ODS Medical as an optical/spectroscopy-based real-time tissue diagnostic medical device.
- Verisante Technology: Canadian company developing Raman spectroscopy-based systems for skin cancer detection. Closely comparable in modality (Raman), clinical use case (cancer detection), and geography (Canada).
- Perimeter Medical Imaging: Canadian AI-enabled OCT imaging company focused on real-time cancer margin assessment in the operating room. Comparable as a Canadian medtech commercializing optical tissue-analysis devices for surgical oncology.
Emerging players
- MedLumics: Develops optical coherence tomography (OCT)-based cardiac imaging catheters. Comparable as a developer of optical diagnostic devices for clinical decision-making, though focused on cardiology rather than oncology/tissue spectroscopy.
- Modulim: Uses spatial frequency domain imaging plus AI for tissue health assessment (e.g., diabetic foot, burns). Adjacent to ODS through the combination of optical physics and AI/ML for tissue characterization in clinical settings.
- SpectralMD: Applies multi-spectral imaging and AI to wound care and burn assessment. Comparable through the use of optical spectroscopy/imaging with machine learning for clinical diagnostics.
Broad incumbents
- Renishaw: Global manufacturer of Raman spectroscopy systems widely used in research and increasingly in medical/clinical research. Comparable as an established supplier of Raman spectroscopy instrumentation, though not exclusively medical-device focused.
- HORIBA Scientific: Major manufacturer of Raman spectrometers and other analytical instruments with medical and life-science applications. Comparable as a broad incumbent in Raman spectroscopy hardware serving clinical and biomedical markets.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
ODS Medical social profiles
Digital presenceODS Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
ODS Medical leadership team
Management profileNumber of profiles
Profiles4 records
ODS Medical funding detail
Funding detailFunding overview
Funding rounds4 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ODS Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ODS Medical
What does ODS Medical do?
ODS Medical is a medical device company developing and seeking to commercialize an exclusive Raman spectroscopy system. The system is positioned for diagnostic and intraoperative clinical applications, enabling optical tissue analysis for medical and surgical use cases. The company's primary commercial objective is to bring this proprietary Raman spectroscopy platform to healthcare markets.
Is ODS Medical a public or private company?
ODS Medical is a private company. It is classified as venture growth investor backed and is currently closed.
When was ODS Medical founded?
ODS Medical was founded in 2015. It employs 11 to 50 people.
Where is ODS Medical based?
ODS Medical is headquartered in Montréal, Canada, in the North America region.
Who are ODS Medical's main competitors?
Direct peers on record are Mauna Kea Technologies, Verisante Technology and Perimeter Medical Imaging. Emerging players are MedLumics, Modulim and SpectralMD. Broad incumbents are Renishaw and HORIBA Scientific.
Does ODS Medical have an API?
No public API is recorded for ODS Medical.
What industry is ODS Medical in?
ODS Medical's product category is Medical Diagnostic Devices. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 334510 and its SIC code is 3841.